Related Experiment Video
Updated: Jul 10, 2025
08:04
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
19.0K
Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK
1Cellular and Molecular Signaling, New York, NY 10022, USA.
Cells
|November 24, 2023
Summary
Innovative therapies targeting non-coding RNA, Wnt signaling, and AMP-activated protein kinase (AMPK) offer new hope for metabolic disorders and diabetes (DM). These approaches address underlying aging mechanisms to improve patient outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Gerontology
Background:
- Metabolic disorders and diabetes (DM) affect over 500 million people globally, causing chronic disability and death.
- Current treatments manage symptoms but cannot halt disease progression or prevent organ damage like dementia.
- Aging disorders, telomere dysfunction, and oxidative stress contribute to multi-system dysfunction in metabolic diseases.
Purpose of the Study:
- To explore innovative therapeutic strategies for metabolic disorders and DM.
- To investigate the role of non-coding RNAs, Wnt signaling, and AMPK in metabolic regulation.
- To highlight the potential of targeting underlying cellular mechanisms for improved clinical outcomes.
Main Methods:
- Investigated non-coding RNA pathways, including microRNAs (miRNAs) and circular RNAs (circRNAs).
- Examined the Wnt signaling pathway and its associated protein WISP1.
- Analyzed cellular metabolic pathways involving AMP-activated protein kinase (AMPK) and nicotinamide.
Main Results:
- Non-coding RNAs, Wnt signaling, and AMPK are identified as key regulators of complex metabolic pathways.
- These pathways are dependent on programmed cell death and cellular metabolism.
- Growth factors also play a role in these metabolic regulatory networks.
Conclusions:
- Non-coding RNAs, Wnt signaling, and AMPK represent promising avenues for novel metabolic disease and DM treatments.
- Understanding the interplay of these mechanisms is crucial for clinical success.
- Targeting these fundamental cellular processes offers a new approach to managing chronic metabolic conditions.
Keywords:
AMP-activated protein kinase (AMPK)WntWnt1 inducible signaling pathway protein 1 (WISP1)agingapoptosisautophagyerythropoietinnicotinamidenon-coding RNAoxidative stressMore Related Videos
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:54Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:25cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K